Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311432964> ?p ?o ?g. }
- W4311432964 endingPage "49" @default.
- W4311432964 startingPage "40" @default.
- W4311432964 abstract "Accelerated approval based on a likely surrogate endpoint can be life-changing for patients suffering from a rare progressive disease with unmet medical need, as it substantially hastens access to potentially lifesaving therapies. In one such example, antisense morpholinos were approved to treat Duchenne muscular dystrophy (DMD) based on measurement of shortened dystrophin in skeletal muscle biopsies as a surrogate biomarker. New, promising therapeutics for DMD include AAV gene therapy to restore another form of dystrophin termed mini- or microdystrophin. AAV-microdystrophins are currently in clinical trials but have yet to be accepted by regulatory agencies as reasonably likely surrogate endpoints. To evaluate microdystrophin expression as a reasonably likely surrogate endpoint for DMD, this review highlights dystrophin biology in the context of functional and clinical benefit to support the argument that microdystrophin proteins have a high probability of providing clinical benefit based on their rational design. Unlike exon-skipping based strategies, the approach of rational design allows for functional capabilities (i.e. quality) of the protein to be maximized with every patient receiving the same optimized microdystrophin. Therefore, the presence of rationally designed microdystrophin in a muscle biopsy is likely to predict clinical benefit and is consequently a strong candidate for a surrogate endpoint analysis to support accelerated approval." @default.
- W4311432964 created "2022-12-26" @default.
- W4311432964 creator A5023439656 @default.
- W4311432964 creator A5024445414 @default.
- W4311432964 creator A5032235028 @default.
- W4311432964 creator A5034642930 @default.
- W4311432964 creator A5038562350 @default.
- W4311432964 creator A5040267061 @default.
- W4311432964 creator A5048992417 @default.
- W4311432964 creator A5050266055 @default.
- W4311432964 creator A5051366982 @default.
- W4311432964 creator A5070311552 @default.
- W4311432964 creator A5075594131 @default.
- W4311432964 creator A5075932899 @default.
- W4311432964 creator A5090570108 @default.
- W4311432964 date "2023-01-01" @default.
- W4311432964 modified "2023-10-18" @default.
- W4311432964 title "Clinical potential of microdystrophin as a surrogate endpoint" @default.
- W4311432964 cites W1584198130 @default.
- W4311432964 cites W1827341666 @default.
- W4311432964 cites W1850477203 @default.
- W4311432964 cites W1902616565 @default.
- W4311432964 cites W1966829370 @default.
- W4311432964 cites W1966925320 @default.
- W4311432964 cites W1967886094 @default.
- W4311432964 cites W1968666078 @default.
- W4311432964 cites W1968869845 @default.
- W4311432964 cites W1973487567 @default.
- W4311432964 cites W1974049989 @default.
- W4311432964 cites W1976919537 @default.
- W4311432964 cites W1986390501 @default.
- W4311432964 cites W1987395460 @default.
- W4311432964 cites W1987768824 @default.
- W4311432964 cites W1989348582 @default.
- W4311432964 cites W1990433203 @default.
- W4311432964 cites W1992677182 @default.
- W4311432964 cites W1996860050 @default.
- W4311432964 cites W1998841070 @default.
- W4311432964 cites W2004740563 @default.
- W4311432964 cites W2006461462 @default.
- W4311432964 cites W2007123925 @default.
- W4311432964 cites W2008115339 @default.
- W4311432964 cites W2009661049 @default.
- W4311432964 cites W2016866192 @default.
- W4311432964 cites W2018600945 @default.
- W4311432964 cites W2030672613 @default.
- W4311432964 cites W2032097547 @default.
- W4311432964 cites W2037305406 @default.
- W4311432964 cites W2041361938 @default.
- W4311432964 cites W2042747686 @default.
- W4311432964 cites W2044962040 @default.
- W4311432964 cites W2046753954 @default.
- W4311432964 cites W2049699926 @default.
- W4311432964 cites W2053068327 @default.
- W4311432964 cites W2053152999 @default.
- W4311432964 cites W2057891939 @default.
- W4311432964 cites W2058807250 @default.
- W4311432964 cites W2064385916 @default.
- W4311432964 cites W2066180106 @default.
- W4311432964 cites W2071403831 @default.
- W4311432964 cites W2071584035 @default.
- W4311432964 cites W2072832813 @default.
- W4311432964 cites W2073645239 @default.
- W4311432964 cites W2080763041 @default.
- W4311432964 cites W2082357253 @default.
- W4311432964 cites W2088637251 @default.
- W4311432964 cites W2094044907 @default.
- W4311432964 cites W2096590729 @default.
- W4311432964 cites W2106185925 @default.
- W4311432964 cites W2111034482 @default.
- W4311432964 cites W2119805163 @default.
- W4311432964 cites W2121650438 @default.
- W4311432964 cites W2126902662 @default.
- W4311432964 cites W2129984947 @default.
- W4311432964 cites W2137484480 @default.
- W4311432964 cites W2137703332 @default.
- W4311432964 cites W2139865704 @default.
- W4311432964 cites W2143738153 @default.
- W4311432964 cites W2147048032 @default.
- W4311432964 cites W2149226097 @default.
- W4311432964 cites W2153648095 @default.
- W4311432964 cites W2156046782 @default.
- W4311432964 cites W2271074088 @default.
- W4311432964 cites W2322780762 @default.
- W4311432964 cites W2344408149 @default.
- W4311432964 cites W2470523364 @default.
- W4311432964 cites W2484125054 @default.
- W4311432964 cites W2606840399 @default.
- W4311432964 cites W2616525826 @default.
- W4311432964 cites W2743090929 @default.
- W4311432964 cites W2785564873 @default.
- W4311432964 cites W2884946171 @default.
- W4311432964 cites W2912811937 @default.
- W4311432964 cites W2945696727 @default.
- W4311432964 cites W2969689255 @default.
- W4311432964 cites W3034565172 @default.
- W4311432964 cites W3118286213 @default.
- W4311432964 cites W3119571546 @default.